A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

NCT01732848 · clinicaltrials.gov ↗

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatitis C

Interventions

DRUG: BMS-986094/INX-08189
DRUG: Placebo matching BMS-986094/INX-08189

Sponsor

Bristol-Myers Squibb